LivaNova PLC
NASDAQ:LIVN
LivaNova PLC
NASDAQ:LIVN
Price:
61.95 USD
-0.74%
Market Closed
Updated:
May 10, 2024
LivaNova PLC
Additional Paid In Capital
|
LivaNova PLC
Additional Paid In Capital Peer Comparison
Comparables:
SN
LMDX
EKF
AGL
CREO
Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
LivaNova PLC
NASDAQ:LIVN
|
Additional Paid In Capital
$2.2B
|
CAGR 3-Years
7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
18%
|
|
|
Smith & Nephew PLC
LSE:SN
|
Additional Paid In Capital
$615m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
LumiraDx Ltd
NASDAQ:LMDX
|
Additional Paid In Capital
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Additional Paid In Capital
£7.4m
|
CAGR 3-Years
233%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-16%
|
|
|
Angle PLC
LSE:AGL
|
Additional Paid In Capital
£115.9m
|
CAGR 3-Years
20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Creo Medical Group PLC
LSE:CREO
|
Additional Paid In Capital
£149.5m
|
CAGR 3-Years
9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is LivaNova PLC's Additional Paid In Capital?
Additional Paid In Capital
2.2B
USD
2.2B
USD
Based on the financial report for Mar 31, 2024, LivaNova PLC's Additional Paid In Capital amounts to 2.2B USD.
What is LivaNova PLC's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
18%
18%
Over the last year, the Additional Paid In Capital growth was 1%. The average annual Additional Paid In Capital growth rates for LivaNova PLC have been 7% over the past three years , 5% over the past five years , and 18% over the past ten years .
You don't have any saved screeners yet
